Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia in Chronic Kidney Disease Patients Not on Dialysis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01750190
What this trial is testing

Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

Who this might be right for
CKD Anemia
Kyntra Bio 922
Large-scale testing (Phase 3)Study completedNCT00598273
What this trial is testing

Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 490
Large-scale testing (Phase 3)Ended earlyNCT00680563
What this trial is testing

Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.

Who this might be right for
Anemia
Hoffmann-La Roche 4
Not applicableStudy completedNCT02042833
What this trial is testing

An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)

Who this might be right for
Anemia
Hoffmann-La Roche 815
Large-scale testing (Phase 3)Study completedNCT00442702
What this trial is testing

Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 228
Testing effectiveness (Phase 2)Ended earlyNCT00968617
What this trial is testing

MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)

Who this might be right for
AnemiaChronic Kidney Disease
Merck Sharp & Dohme LLC 7
Not applicableNo Longer AvailableNCT01892202
What this trial is testing

A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00255437
What this trial is testing

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Who this might be right for
Anemia
AMAG Pharmaceuticals, Inc. 304
Not applicableStudy completedNCT02238067
What this trial is testing

Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis

Who this might be right for
Chronic Kidney Diseases
Hoffmann-La Roche 196
Testing effectiveness (Phase 2)Study completedNCT00680043
What this trial is testing

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Who this might be right for
AnemiaChronic Renal FailureChronic Kidney Disease
Affymax 114
Testing effectiveness (Phase 2)Study completedNCT00228436
What this trial is testing

Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 139
Testing effectiveness (Phase 2)Study completedNCT01964196
What this trial is testing

ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

Who this might be right for
Anemia in Chronic Kidney Disease Patients Not on Dialysis
Astellas Pharma Inc 107
Testing effectiveness (Phase 2)UnknownNCT02403362
What this trial is testing

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT03552393
What this trial is testing

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Hoffmann-La Roche 40
Post-approval studies (Phase 4)Study completedNCT00773513
What this trial is testing

Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Who this might be right for
Chronic Renal Anemia
Hoffmann-La Roche 2,825
Large-scale testing (Phase 3)Study completedNCT00559273
What this trial is testing

Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Renal Anemia, Chronic
Hoffmann-La Roche 307
Large-scale testing (Phase 3)Study completedNCT00236964
What this trial is testing

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

Who this might be right for
Anemia
American Regent, Inc. 96
Testing effectiveness (Phase 2)Ended earlyNCT00109291
What this trial is testing

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 17
Not applicableStudy completedNCT01695746
What this trial is testing

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 108
Large-scale testing (Phase 3)Study completedNCT04012957
What this trial is testing

Desidustat in the Treatment of Anemia in CKD

Who this might be right for
Chronic Kidney Disease Stage 3AnemiaChronic Kidney Disease Stage 4+1 more
Zydus Lifesciences Limited 588
Next Page